secwatch.observer — SEC 8-K summary
======================================

Issuer:     COOPER COMPANIES, INC. (COO)
CIK:        0000711404
Form:       8-K
Filed at:   2026-06-04T20:27:28+00:00
Accession:  0001628280-26-040823
Event type: other_material
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CooperCompanies Q2 revenue $1.082B (+8% YoY); non-GAAP EPS $1.21 (+26%); records $271.6M litigation charge
--------------------------------------------------------------------------------

- Revenue $1.082B (+8% reported, +5% organic); CooperVision $723.5M (+8%), CooperSurgical $358.0M (+8%).
- GAAP diluted EPS of $(0.40) due to $271.6M net litigation charge; non-GAAP diluted EPS $1.21, up 26% YoY.
- Recorded $271.6M net charge ($324.1M liabilities less $52.5M insurance) for CooperSurgical fertility media recall; settled >95% of over 1,500 claimants.
- Fiscal 2026 guidance: revenue $4.285-$4.321B; non-GAAP diluted EPS $4.58-$4.66; reaffirms long-term free cash flow target >$2.2B for FY26-28.
- Repurchased $13.1M in common stock (174k shares) at avg $75.84; $860.8M remaining under buyback authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/0001628280-26-040823-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/coo-20260604.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-040823

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer